In October of last year, Medtronic made headlines when it reported that it was going to acquire Changzhou holdings, a China-based company that is a provider of orthopedic devices, for $816 million. Now the acquisition, in my opinion was perhaps the loudest shot fired in the battle to maintain a dominant presence in China one of the fastest growing emerging markets. Last month, Stryker responded in kind with its plan to acquire Trauson Holdings, a China-based firm that specializes in products for the spine for $764 million. After listening to a webinar from Millinneum Research Group, about the Top 10...